SEC Form 4 · accession 0001645627-17-000089
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jun 30, 2017
Accepted (ET)
Jul 5, 2017 · 3:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.03 | A | 21,467,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.028 | A | 21,469,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.0314 | A | 21,471,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.0319 | A | 21,473,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.0319 | A | 21,475,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.028 | A | 21,477,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.028 | A | 21,479,349 | D | |
| Common Stock | Jun 30, 2017 | P | 4,000 | $0.028 | A | 21,483,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.028 | A | 21,485,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.0279 | A | 21,487,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.028 | A | 21,489,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.028 | A | 21,491,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.028 | A | 21,493,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.028 | A | 21,495,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.028 | A | 21,497,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.028 | A | 21,499,349 | D | |
| Common Stock | Jun 30, 2017 | P | 2,000 | $0.028 | A | 21,501,349 | D |
Table II — derivative securities
No Table II lines on this filing.